Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 07, 2019

SELL
$26.93 - $34.7 $2,693 - $3,470
-100 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$27.23 - $45.56 $2,723 - $4,556
100 New
100 $3,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.77B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Karp Capital Management Corp Portfolio

Follow Karp Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Karp Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Karp Capital Management Corp with notifications on news.